Reserpine
- TRADE NAMES: Anserpin; Inerpin; Novo-Reserpine; Resa; Reserfia; Sedaraupin; Ser-Ap-Es (Novartis); Serpalan; Serpasil (Novartis); Serpasol; Serpatabs; Tionsera
- INDICATIONS: Hypertension
- CLASS: Rauwolfia alkaloid
- HALF-LIFE: 50–100 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atenolol, Bisoprolol, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Iobenguane, Linezolid, Metipranolol, Oxprenolol, Sotalol, St John's Wort, Tetrabenazine
PREGNANCY CATEGORY: C
Ser-Ap-Es is reserpine, hydralazine and hydrochlorothiazide.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
Page last updated 09/03/2019
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric